Regulation of sphingomyelin metabolism

Filippov, 2006, Sphingomyelin structure influences the lateral diffusion and raft formation in lipid bilayers, Biophys J, 90, 2086, 10.1529/biophysj.105.075150

Stillwell, 2013

Karlsson, 1998, Molecular species of sphingomyelin: determination by high-performance liquid chromatography/mass spectrometry with electrospray and high-performance liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization, J Mass Spectrom, 33, 1192, 10.1002/(SICI)1096-9888(199812)33:12<1192::AID-JMS735>3.0.CO;2-J

Furland, 2007, Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells, J Biol Chem, 282, 18141, 10.1074/jbc.M700708200

Ramstedt, 2002, Membrane properties of sphingomyelins, FEBS Lett, 531, 33, 10.1016/S0014-5793(02)03406-3

Kuikka, 2001, Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species, Biophys J, 80, 2327, 10.1016/S0006-3495(01)76203-0

Kan, 1991, Interaction of cholesterol with sphingomyelin in bilayer membranes: evidence that the hydroxy group of sphingomyelin does not modulate the rate of cholesterol exchange between vesicles, Biochemistry, 30, 7759, 10.1021/bi00245a013

Needham, 1990, Elastic deformation and failure of lipid bilayer membranes containing cholesterol, Biophys J, 58, 997, 10.1016/S0006-3495(90)82444-9

Schroeder, 1998, Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains, J Biol Chem, 273, 1150, 10.1074/jbc.273.2.1150

Prinetti, 2001, Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro, J Biol Chem, 276, 21136, 10.1074/jbc.M010666200

Koval, 1991, Intracellular transport and metabolism of sphingomyelin, Biochim Biophys Acta, 1082, 113, 10.1016/0005-2760(91)90184-J

Ramstedt, 1999, Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length, Biophys J, 76, 908, 10.1016/S0006-3495(99)77254-1

Bittman, 1994, Interaction of cholesterol with sphingomyelin in monolayers and vesicles, Biochemistry, 33, 11776, 10.1021/bi00205a013

Jaikishan, 2010, Sphingomyelin analogs with branched N-acyl chains: the position of branching dramatically affects acyl chain order and sterol interactions in bilayer membranes, Biochim Biophys Acta, 1798, 1987, 10.1016/j.bbamem.2010.07.006

Ramstedt, 1999, Comparison of the biophysical properties of racemic and d-erythro-N-acyl sphingomyelins, Biophys J, 77, 1498, 10.1016/S0006-3495(99)76997-3

Bini, 2003, Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering, Biochem J, 369, 301, 10.1042/bj20020503

Brown, 2000, Structure and function of sphingolipid- and cholesterol-rich membrane rafts, J Biol Chem, 275, 17221, 10.1074/jbc.R000005200

Merrill, 1993, Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ, J Biol Chem, 268, 27299, 10.1016/S0021-9258(19)74249-5

Schweizer, 1994, Localization of O-glycan initiation, sphingomyelin synthesis, and glucosylceramide synthesis in Vero cells with respect to the endoplasmic reticulum-Golgi intermediate compartment, J Biol Chem, 269, 4035, 10.1016/S0021-9258(17)41738-8

Funato, 2001, Vesicular and nonvesicular transport of ceramide from ER to the Golgi apparatus in yeast, J Cell Biol, 155, 949, 10.1083/jcb.200105033

Hanada, 2010, Intracellular trafficking of ceramide by ceramide transfer protein, Proc Jpn Acad Ser B Phys Biol Sci, 86, 426, 10.2183/pjab.86.426

Wang, 2009, Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice, J Cell Biol, 184, 143, 10.1083/jcb.200807176

Futerman, 1990, Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus, J Biol Chem, 265, 8650, 10.1016/S0021-9258(19)38937-9

van Meer, 2000, Sphingolipid transport in eukaryotic cells, Biochim Biophys Acta, 1486, 145, 10.1016/S1388-1981(00)00054-8

Schuchman, 1991, Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs, J Biol Chem, 266, 8531, 10.1016/S0021-9258(18)93007-3

Wu, 2010, Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses, Neuromolecular Med, 12, 320, 10.1007/s12017-010-8120-z

Milhas, 2010, Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids, FEBS Lett, 584, 1887, 10.1016/j.febslet.2009.10.058

Ding, 2015, All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity, J Lipid Res, 56, 537, 10.1194/jlr.M054627

Yeang, 2011, Subcellular targeting domains of sphingomyelin synthase 1 and 2, Nutr Metab (Lond), 8, 89, 10.1186/1743-7075-8-89

Yeang, 2008, The domain responsible for sphingomyelin synthase (SMS) activity, Biochim Biophys Acta, 1781, 610, 10.1016/j.bbalip.2008.07.002

Li, 2007, Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization, Biochim Biophys Acta, 1771, 1186, 10.1016/j.bbalip.2007.05.007

Tafesse, 2007, Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells, J Biol Chem, 282, 17537, 10.1074/jbc.M702423200

Sudarkina, 2015, Comparative analysis of sphingomyelin synthase 1 gene expression at the transcriptional and translational levels in human tissues, Mol Cell Biochem, 406, 91, 10.1007/s11010-015-2427-x

Huitema, 2004, Identification of a family of animal sphingomyelin synthases, EMBO J, 23, 33, 10.1038/sj.emboj.7600034

Tafesse, 2006, The multigenic sphingomyelin synthase family, J Biol Chem, 281, 29421, 10.1074/jbc.R600021200

Wesley, 2015, Sphingomyelin synthase 1 regulates neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt signaling, Mol Neurobiol, 51, 1530, 10.1007/s12035-014-8829-z

Taniguchi, 2014, The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders, Biochim Biophys Acta, 1841, 692, 10.1016/j.bbalip.2013.12.003

Lafont, 2010, Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death, Cell Death Differ, 17, 642, 10.1038/cdd.2009.130

Riboni, 2001, Basic fibroblast growth factor-induced proliferation of primary astrocytes. Evidence for the involvement of sphingomyelin biosynthesis, J Biol Chem, 276, 12797, 10.1074/jbc.M011570200

Luberto, 1998, Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?, J Biol Chem, 273, 14550, 10.1074/jbc.273.23.14550

Cai, 1997, Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity, J Biol Chem, 272, 6918, 10.1074/jbc.272.11.6918

Taguchi, 2004, Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase, Blood, 104, 3285, 10.1182/blood-2004-03-0900

Dong, 2012, CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice, Int Immunol, 24, 327, 10.1093/intimm/dxs008

Goñi, 1999, Structure and functional properties of diacylglycerols in membranes, Prog Lipid Res, 38, 1, 10.1016/S0163-7827(98)00021-6

Evangelisti, 2007, Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks, Histol Histopathol, 22, 573

Momchilova, 1999, Phosphatidylethanolamine and phosphatidylcholine are sources of diacylglycerol in ras-transformed NIH 3T3 fibroblasts, Int J Biochem Cell Biol, 31, 311, 10.1016/S1357-2725(98)00111-3

Tani, 2009, Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes, Biochem Biophys Res Commun, 381, 328, 10.1016/j.bbrc.2009.02.063

Hailemariam, 2008, Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation, Arterioscler Thromb Vasc Biol, 28, 1519, 10.1161/ATVBAHA.108.168682

Ternes, 2009, Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase, J Lipid Res, 50, 2270, 10.1194/jlr.M900230-JLR200

Kidani, 2012, Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation, Biochem Biophys Res Commun, 417, 1014, 10.1016/j.bbrc.2011.12.079

Zhang, 2011, The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain, Biochem Pharmacol, 82, 287, 10.1016/j.bcp.2011.04.009

Vacaru, 2009, Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER, J Cell Biol, 185, 1013, 10.1083/jcb.200903152

Marathe, 1998, Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling, J Biol Chem, 273, 4081, 10.1074/jbc.273.7.4081

Schissel, 1996, Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene, J Biol Chem, 271, 18431, 10.1074/jbc.271.31.18431

Ferlinz, 1997, Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis, Eur J Biochem, 243, 511, 10.1111/j.1432-1033.1997.511_1a.x

Schissel, 1998, Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development, J Biol Chem, 273, 2738, 10.1074/jbc.273.5.2738

Spence, 1989, A new Zn2+-stimulated sphingomyelinase in fetal bovine serum, J Biol Chem, 264, 5358, 10.1016/S0021-9258(18)83553-0

Levade, 1986, Sphingomyelinases, and Niemann–Pick disease, J Clin Chem Clin Biochem, 24, 205

Takahashi, 2000, Distribution of acid sphingomyelinase in human various body fluids, Tohoku J Exp Med, 192, 61, 10.1620/tjem.192.61

Mühle, 2013, Characterization of acid sphingomyelinase activity in human cerebrospinal fluid, PLOS ONE, 8, e62912, 10.1371/journal.pone.0062912

Simon, 1998, Sphingomyelinase activity in human platelets, Thromb Res, 90, 155, 10.1016/S0049-3848(98)00033-4

Romiti, 2000, Characterization of sphingomyelinase activity released by thrombin-stimulated platelets, Mol Cell Biochem, 205, 75, 10.1023/A:1007041329052

Vasta, 1997, Sphingomyelinase increases 2-deoxyglucose uptake and glucose metabolism of human platelets, Biochem Mol Biol Int, 43, 217

Münzer, 2014, Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation, Arterioscler Thromb Vasc Biol, 34, 61, 10.1161/ATVBAHA.112.300210

Kitatani, 2000, Acceleration by ceramide of calcium-dependent translocation of phospholipase A2 from cytosol to membranes in platelets, Arch Biochem Biophys, 382, 296, 10.1006/abbi.2000.2028

Hofmann, 2000, Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase, Proc Natl Acad Sci U S A, 97, 5895, 10.1073/pnas.97.11.5895

Tomiuk, 1998, Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?, Proc Natl Acad Sci U S A, 95, 3638, 10.1073/pnas.95.7.3638

Tani, 2007, Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization, J Biol Chem, 282, 10047, 10.1074/jbc.M611249200

Crivello, 2005, Age-related changes in neutral sphingomyelin-specific phospholipase C activity in striatum, hippocampus, and frontal cortex: implication for sensitivity to stress and inflammation, Neurochem Int, 47, 573, 10.1016/j.neuint.2005.06.011

Stoffel, 2005, Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development, Proc Natl Acad Sci U S A, 102, 4554, 10.1073/pnas.0406380102

Wheeler, 2009, Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors, J Neurochem, 109, 1237, 10.1111/j.1471-4159.2009.06038.x

Kim, 2010, Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium, Cell Signal, 22, 865, 10.1016/j.cellsig.2010.01.012

Zheng, 2000, Sphingomyelinase ceramide analogs induce contraction and rises in [Ca(2+)](i) in canine cerebral vascular muscle, Am J Physiol Heart Circ Physiol, 278, H1421, 10.1152/ajpheart.2000.278.5.H1421

Bautista-Pérez, 2015, Involvement of neutral sphingomyelinase in the angiotensin II signaling pathway, Am J Physiol Renal Physiol, 308, F1178, 10.1152/ajprenal.00079.2014

Mogami, 2005, Sphingomyelinase causes endothelium-dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca(2+) elevation, FEBS Lett, 579, 393, 10.1016/j.febslet.2004.11.100

Mueller, 2014, Neutral sphingomyelinase in physiological and measles virus induced T cell suppression, PLoS Pathog, 10, e1004574, 10.1371/journal.ppat.1004574

Khavandgar, 2015, Sphingolipid metabolism and its role in the skeletal tissues, Cell Mol Life Sci, 72, 959, 10.1007/s00018-014-1778-x

Aubin, 2005, A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse, Nat Genet, 37, 803, 10.1038/ng1603

Stoffel, 2007, Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression, Am J Pathol, 171, 153, 10.2353/ajpath.2007.061285

Tomiuk, 2000, Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase, J Biol Chem, 275, 5710, 10.1074/jbc.275.8.5710

Mizutani, 2001, Nuclear localization of neutral sphingomyelinase 1: biochemical and immunocytochemical analyses, J Cell Sci, 114, 3727, 10.1242/jcs.114.20.3727

Sawai, 1999, Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C, J Biol Chem, 274, 38131, 10.1074/jbc.274.53.38131

Zumbansen, 2002, Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease, Mol Cell Biol, 22, 3633, 10.1128/MCB.22.11.3633-3638.2002

Tonnetti, 1999, A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction, J Exp Med, 189, 1581, 10.1084/jem.189.10.1581

Yabu, 2008, Identification of Mg2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis, J Biol Chem, 283, 29971, 10.1074/jbc.M805402200

Yabu, 2015, Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling, Cell Death Differ, 22, 258, 10.1038/cdd.2014.128

Guo, 2015, The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes, J Biol Chem, 290, 3455, 10.1074/jbc.M114.605253

Krut, 2006, Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein, J Biol Chem, 281, 13784, 10.1074/jbc.M511306200

Corcoran, 2008, Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies, Mol Cancer Res, 6, 795, 10.1158/1541-7786.MCR-07-2097

Moylan, 2014, Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle, Redox Biol, 2, 910, 10.1016/j.redox.2014.07.006

Wu, 2010, Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5, J Biol Chem, 285, 17993, 10.1074/jbc.M110.102988

Rajagopalan, 2015, Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization, Biochim Biophys Acta, 1850, 628, 10.1016/j.bbagen.2014.11.019

Birbes, 2005, A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria, Biochem J, 386, 445, 10.1042/BJ20041627

Petcoff, 2008, Lipid levels in sperm, eggs, and during fertilization in Xenopus laevis, J Lipid Res, 49, 2365, 10.1194/jlr.M800159-JLR200

Furland, 2007, Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa, J Biol Chem, 282, 18151, 10.1074/jbc.M700709200

Duan, 2003, Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family, J Biol Chem, 278, 38528, 10.1074/jbc.M305437200

Duan, 1997, Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity, Hepatology, 26, 823, 10.1002/hep.510260403

Nyberg, 1997, Localization and capacity of sphingomyelin digestion in the rat intestinal tract, J Nutr Biochem, 8, 112, 10.1016/S0955-2863(97)00010-7

Kubota, 1996, Sphingomyelin changes in rat cerebral cortex during focal ischemia, Neurol Res, 18, 337, 10.1080/01616412.1996.11740432

Nakane, 2000, Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus, Neurosci Lett, 296, 89, 10.1016/S0304-3940(00)01655-4

Tian, 2009, Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia, Brain Inj, 23, 1073, 10.3109/02699050903379388

Soeda, 2004, Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress, Neurochem Int, 45, 619, 10.1016/j.neuint.2004.04.001

Liu, 1998, Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain, J Biol Chem, 273, 34472, 10.1074/jbc.273.51.34472

Yoshimura, 1998, Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation, J Biol Chem, 273, 6921, 10.1074/jbc.273.12.6921

Yoshimura, 1999, Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death, J Neurochem, 73, 675, 10.1046/j.1471-4159.1999.0730675.x

Bernardo, 2000, Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain, J Biol Chem, 275, 7641, 10.1074/jbc.275.11.7641

Gu, 2013, Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi, J Neuroinflammation, 10, 109, 10.1186/1742-2094-10-109

Ohtani, 2004, Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia, Brain Res, 1023, 31, 10.1016/j.brainres.2004.07.024

Yamashima, 2014, Calpain-mediated Hsp70.1 cleavage in monkey CA1 after ischemia induces similar ‘lysosomal vesiculosis’ to Alzheimer neurons, J Alzheimers Dis Parkinsonism, 4, 139, 10.4172/2161-0460.1000139

Yu, 2000, Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis, J Mol Neurosci, 15, 85, 10.1385/JMN:15:2:85

Yu, 2007, JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction, J Biol Chem, 282, 25940, 10.1074/jbc.M701812200

Jin, 2008, Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells, J Biol Chem, 283, 26509, 10.1074/jbc.M801597200

Lam, 2014, Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia, Neurobiol Aging, 35, 2369, 10.1016/j.neurobiolaging.2014.02.025

Chan, 2012, Comparative lipidomic analysis of mouse and human brain with Alzheimer disease, J Biol Chem, 287, 2678, 10.1074/jbc.M111.274142

Ben-David, 2011, Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels, J Biol Chem, 286, 30022, 10.1074/jbc.M111.261206

Adam-Klages, 1996, FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase, Cell, 86, 937, 10.1016/S0092-8674(00)80169-5

Philipp, 2010, The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase, Proc Natl Acad Sci U S A, 107, 1112, 10.1073/pnas.0908486107

Lavrentiadou, 2001, Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione, Am J Respir Cell Mol Biol, 25, 676, 10.1165/ajrcmb.25.6.4321

Yamagata, 2009, Vitamin E regulates SMase activity, GSH levels, and inhibits neuronal death in stroke-prone spontaneously hypertensive rats during hypoxia and reoxygenation, J Exp Stroke Transl Med, 2, 41, 10.6030/1939-067X-2.2.41

Won, 2006, Sphingolipid signaling and redox regulation, Free Radic Biol Med, 40, 1875, 10.1016/j.freeradbiomed.2006.01.035

Li, 2012, Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase, Cell Physiol Biochem, 30, 815, 10.1159/000341460

Wei, 2013, Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation, J Immunol, 190, 138, 10.4049/jimmunol.1103721

Dmitrieva, 2008, Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia, Brain Res, 1188, 222, 10.1016/j.brainres.2007.10.056

Morishima-Kawashima, 2002, Alzheimer's disease: beta-amyloid protein and tau, J Neurosci Res, 70, 392, 10.1002/jnr.10355

Orešič, 2011, Metabolome in progression to Alzheimer's disease, Transl Psychiatry, 1, e57, 10.1038/tp.2011.55

Mielke, 2010, Serum sphingomyelins and ceramides are early predictors of memory impairment, Neurobiol Aging, 31, 17, 10.1016/j.neurobiolaging.2008.03.011

Mielke, 2012, Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II, Neurology, 79, 633, 10.1212/WNL.0b013e318264e380

Kosicek, 2010, Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients – a pilot study, Anal Bioanal Chem, 398, 2929, 10.1007/s00216-010-4273-8

Kosicek, 2012, Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease, Neurosci Lett, 516, 302, 10.1016/j.neulet.2012.04.019

Mielke, 2014, Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease, Neurobiol Aging, 35, 2486, 10.1016/j.neurobiolaging.2014.05.019

Gottfries, 1996, Reductions in membrane proteins and lipids in basal ganglia of classic Alzheimer disease patients, Alzheimer Dis Assoc Disord, 10, 77, 10.1097/00002093-199601020-00004

Söderberg, 1992, Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type, J Neurochem, 59, 1646, 10.1111/j.1471-4159.1992.tb10994.x

He, 2010, Deregulation of sphingolipid metabolism in Alzheimer's disease, Neurobiol Aging, 31, 398, 10.1016/j.neurobiolaging.2008.05.010

Gulbins, 2003, Regulation of death receptor signaling and apoptosis by ceramide, Pharmacol Res, 47, 393, 10.1016/S1043-6618(03)00052-5

Panchal, 2014, Ceramides and sphingomyelinases in senile plaques, Neurobiol Dis, 65, 193, 10.1016/j.nbd.2014.01.010

González-Domínguez, 2014, Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease, Biochim Biophys Acta, 1842, 2395, 10.1016/j.bbadis.2014.09.014

Tajima, 2013, Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease, Lipids Health Dis, 12, 68, 10.1186/1476-511X-12-68

Cordy, 2006, The involvement of lipid rafts in Alzheimer's disease, Mol Membr Biol, 23, 111, 10.1080/09687860500496417

Schengrund, 2010, Lipid rafts: keys to neurodegeneration, Brain Res Bull, 82, 7, 10.1016/j.brainresbull.2010.02.013

Fabelo, 2014, Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions, Neurobiol Aging, 35, 1801, 10.1016/j.neurobiolaging.2014.02.005

Díaz, 2015, Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease, J Alzheimers Dis, 43, 1185, 10.3233/JAD-141146

Clement, 2010, Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein, Free Radic Biol Med, 48, 1236, 10.1016/j.freeradbiomed.2010.02.008

Ayasolla, 2004, Inflammatory mediator and beta-amyloid (25e35)-induced ceramide generation and iNOS expression are inhibited by vitamin E, Free Radic Biol Med, 37, 325, 10.1016/j.freeradbiomed.2004.04.007

Grimm, 2005, Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin, Nat Cell Biol, 7, 1118, 10.1038/ncb1313

Dinkins, 2014, Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease, Neurobiol Aging, 35, 1792, 10.1016/j.neurobiolaging.2014.02.012

Yuyama, 2012, Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia, J Biol Chem, 287, 10977, 10.1074/jbc.M111.324616

Lee, 2014, Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease, J Exp Med, 211, 1551, 10.1084/jem.20132451

Bandaru, 2009, ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain, Neurobiol Aging, 30, 591, 10.1016/j.neurobiolaging.2007.07.024

Maes, 1997, Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers, Acta Psychiatr Scand, 95, 212, 10.1111/j.1600-0447.1997.tb09622.x

Musselman, 1998, The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment, Arch Gen Psychiatry, 55, 580, 10.1001/archpsyc.55.7.580

Cizza, 2001, Depression: a major, unrecognized risk factor for osteoporosis?, Trends Endocrinol Metab, 12, 198, 10.1016/S1043-2760(01)00407-6

Demirkan, 2013, Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study, J Psychiatr Res, 47, 357, 10.1016/j.jpsychires.2012.11.001

Kornhuber, 2005, High activity of acid sphingomyelinase in major depression, J Neural Transm (Vienna), 112, 1583, 10.1007/s00702-005-0374-5

Geddes, 2015, Time-dependent modulation of glutamate synapses onto 5-HT neurons by antidepressant treatment, Neuropharmacology, 95, 130, 10.1016/j.neuropharm.2015.02.027

Meneses, 2002, Tianeptine: 5-HT uptake sites and 5-HT(1–7) receptors modulate memory formation in an autoshaping Pavlovian/instrumental task, Neurosci Biobehav Rev, 26, 309, 10.1016/S0149-7634(02)00005-2

Sjögren, 2007, Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells, Acta Physiol (Oxf), 190, 47, 10.1111/j.1365-201X.2007.01687.x

Weng, 2015, Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry, Rapid Commun Mass Spectrom, 29, 1491, 10.1002/rcm.7241

Kornhuber, 2010, Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications, Cell Physiol Biochem, 26, 9, 10.1159/000315101

Gulbins, 2013, Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs, Nat Med, 19, 934, 10.1038/nm.3214

Keshavan, 1993, Erythrocyte membrane phospholipids in psychotic patients, Psychiatry Res, 49, 89, 10.1016/0165-1781(93)90032-C

Ponizovsky, 2001, Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology, Schizophr Res, 52, 121, 10.1016/S0920-9964(00)00189-4

Schmitt, 2004, Altered thalamic membrane phospholipids in schizophrenia: a postmortem study, Biol Psychiatry, 56, 41, 10.1016/j.biopsych.2004.03.019

Colón-Sáez, 2011, α7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane, J Physiol, 589, 3163, 10.1113/jphysiol.2011.209494

Eriksen, 2005, Molecular pathogenesis of Parkinson disease, Arch Neurol, 62, 353, 10.1001/archneur.62.3.353

Xilouri, 2008, Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis, Autophagy, 4, 917, 10.4161/auto.6685

Dagan, 2015, The contribution of Niemann–Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews, Parkinsonism Relat Disord, 21, 1067, 10.1016/j.parkreldis.2015.06.016

Foo, 2013, Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease, Neurobiol Aging, 34, 10.1016/j.neurobiolaging.2013.06.010

Gan-Or, 2013, The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease, Neurology, 80, 1606, 10.1212/WNL.0b013e31828f180e

Das, 2015, Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission, Philos Trans R Soc Lond B Biol Sci, 370, 10.1098/rstb.2014.0187

Leftin, 2013, Solid-state 13C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein α-Synuclein, J Mol Biol, 425, 2973, 10.1016/j.jmb.2013.04.002

Sidransky, 2009, Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, N Engl J Med, 361, 1651, 10.1056/NEJMoa0901281

Gegg, 2015, No evidence for substrate accumulation in Parkinson brains with GBA mutations, Mov Disord, 30, 1085, 10.1002/mds.26278

Fabelo, 2011, Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease, Mol Med, 17, 1107, 10.2119/molmed.2011.00119

Abbott, 2014, Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease, Mov Disord, 29, 518, 10.1002/mds.25729

Wang, 2015, Neuroinflammation in Parkinson's disease and its potential as therapeutic target, Transl Neurodegener, 4, 19, 10.1186/s40035-015-0042-0

Hunot, 1997, Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease, Proc Natl Acad Sci U S A, 94, 7531, 10.1073/pnas.94.14.7531

He, 2001, An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann–Pick disease, Anal Biochem, 293, 204, 10.1006/abio.2001.5108

Lozano, 2001, Disease versus acid sphingomyelinase deficiency, Cell Death Differ, 8, 100, 10.1038/sj.cdd.4400775

Levran, 1991, A frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients, Proc Natl Acad Sci U S A, 88, 3748, 10.1073/pnas.88.9.3748

Simonaro, 2002, The demographics and distribution of type B Niemann–Pick disease: novel mutations lead to new genotype/phenotype correlations, Am J Hum Genet, 71, 1413, 10.1086/345074

Tóth, 2012, Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing Niemann–Pick disease, JIMD Rep, 3, 125, 10.1007/8904_2011_80

Zhang, 2013, Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann–Pick disease, Orphanet J Rare Dis, 8, 15, 10.1186/1750-1172-8-15

Irun, 2013, Identification of seven novel SMPD1 mutations causing Niemann–Pick disease types A and B, Clin Genet, 84, 356, 10.1111/cge.12076

Manshadi, 2015, Four novel p.N385K, p.V36A, c.1033-1034insT and c.1417-1418delCT mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene in patients with types A and B Niemann–Pick disease (NPD), Int J Mol Sci, 16, 6668, 10.3390/ijms16046668

Kwon, 2009, Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol, Cell, 137, 1213, 10.1016/j.cell.2009.03.049

Vanier, 2004, Structure and function of the NPC2 protein, Biochim Biophys Acta, 1685, 14, 10.1016/j.bbalip.2004.08.007

Thomas, 1989, Correction of sphingomyelinase deficiency in Niemann–Pick type C fibroblasts by removal of lipoprotein fraction from culture media, J Inherit Metab Dis, 12, 139, 10.1007/BF01800716

Pentchev, 1985, A defect in cholesterol esterification in Niemann–Pick disease (type C) patients, Proc Natl Acad Sci U S A, 82, 8247, 10.1073/pnas.82.23.8247

McGovern, 2006, Natural history of type A Niemann–Pick disease; possible endpoints for therapeutic trials, Neurology, 66, 228, 10.1212/01.wnl.0000194208.08904.0c

Wasserstein, 2004, The natural history of type B Niemann–Pick disease: results from a 10-year longitudinal study, Pediatrics, 114, e672, 10.1542/peds.2004-0887

Wasserstein, 2003, Growth restriction in children with type B Niemann–Pick disease, J Pediatr, 142, 424, 10.1067/mpd.2003.113

Marathe, 2000, Hum Mol Genet, 9, 1967, 10.1093/hmg/9.13.1967

Gabandé-Rodríguez, 2014, High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A, Cell Death Differ, 21, 864, 10.1038/cdd.2014.4

Macauley, 2008, Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann–Pick A disease including structure–function studies associated with cerebellar Purkinje cell degeneration, Exp Neurol, 214, 181, 10.1016/j.expneurol.2008.07.026

Miranda, 2000, Infusion of recombinant human acid sphingomyelinase into Niemann–Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology, FASEB J, 14, 1988, 10.1096/fj.00-0014com

Dodge, 2009, Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann–Pick A disease, Exp Neurol, 215, 349, 10.1016/j.expneurol.2008.10.021

Murray, 2015, Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: the utility of animal models of disease in the toxicological evaluation of potential therapeutics, Mol Genet Metab, 114, 217, 10.1016/j.ymgme.2014.07.005